Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
Showing 281 - 300 results of 4,368 for search '(( significant decrease decrease ) OR ( significant clinical decrease ))~', query time: 0.34s Refine Results
  1. 281
    Sample Pain Diagrams.

    Sample Pain Diagrams. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 282
    Patient Example.

    Patient Example. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 283
    Clinical diagnosis and abnormal signals of AEFIs(/10,000).

    Clinical diagnosis and abnormal signals of AEFIs(/10,000). by Chao Zhang (51048)

    Published 2025
    Save to List
    Saved in:
  4. 284
    Clinical prognosis analysis of other DE-ERSRGs except PDHB.

    Clinical prognosis analysis of other DE-ERSRGs except PDHB. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 285
    Synthesis and Preclinical Evaluation of Novel <sup>99m</sup>Tc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake

    Synthesis and Preclinical Evaluation of Novel <sup>99m</sup>Tc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake by Junhong Feng (11835903)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 286
    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. However, M:D FMT products exhibited the smallest median loss of bacterial viability following lyophilization and outperforms other lyopreservatives. Data is represented as median and range in parentheses. Significant p-values are bolded. Abbreviations: C, centrifuged; NC, not centrifuged; MD, maltodextrin and trehalose.

    Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the g... by Nina K. Randolph (21030732)

    Published 2025
    Save to List
    Saved in:
  7. 287
    ZLN005 and metformin cell toxicity.

    ZLN005 and metformin cell toxicity. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 288
    ZLN005 increases PGC-1α and TFAM expression.

    ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 289
    ZLN005 and metformin toxicity in MAC.

    ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 290
    Full Western blot images from manuscript.

    Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 291
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 292
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 293
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 294
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 295
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 296
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 297
    Clinical characteristics of the study population.

    Clinical characteristics of the study population. by Sergio R. Thomaz (20308465)

    Published 2024
    “…There were significant decreases in the ΔMLwHFQ in the CRT group vs. …”
    Save to List
    Saved in:
  18. 298
    Summary map of all contacts with statistically significant SVM classifications.

    Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

    Published 2024
    Save to List
    Saved in:
  19. 299
    Demographics and clinical features of healthy controls and primary Sjögren’s Syndrome patients.

    Demographics and clinical features of healthy controls and primary Sjögren’s Syndrome patients. by Songyan Zou (11399489)

    Published 2025
    Save to List
    Saved in:
  20. 300
    Comparing demographic and clinical characteristics of patients before and COVID-19 outbreak.

    Comparing demographic and clinical characteristics of patients before and COVID-19 outbreak. by Mahsa Motiei (18275525)

    Published 2025
    Save to List
    Saved in:

Search Tools: